Roth MKM Initiates Coverage On Replimune Group with Buy Rating, Announces Price Target of $17
Portfolio Pulse from Benzinga Newsdesk
Roth MKM has initiated coverage on Replimune Group with a Buy rating and set a price target of $17.
August 27, 2024 | 10:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Roth MKM has initiated coverage on Replimune Group with a Buy rating and a price target of $17, indicating a positive outlook.
The initiation of coverage with a Buy rating and a specific price target of $17 by Roth MKM suggests a positive outlook for Replimune Group. This can lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100